CRISPR Therapeutics vs Mammoth Biosciences

CRISPR Therapeutics vs Mammoth Biosciences, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CRISPR Therapeutics is on 64/100 and Mammoth Biosciences on 63/100.

CRISPR Therapeutics logo
CRISPR TherapeuticsBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
Try CRISPR Therapeutics
Mammoth Biosciences logo
Mammoth BiosciencesBiotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.
Try Mammoth Biosciences

Where each one leads

CRISPR Therapeutics

  • agent readiness: 44/100 against 35/100
  • domain rating: 67/100 against 53/100

Mammoth Biosciences

Leads on none of the measures we hold for both companies.

At a glance

MeasureCRISPR TherapeuticsMammoth Biosciences
What it isBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.
CategoryBiotechnology, Gene Editing, Therapeutics, PharmaceuticalsBiotechnology, Drug Discovery, Genomics, CRISPR Technology
Sells toBusiness modelB2BB2B
OfferingPlatformPlatform
Founded20132017
HeadquartersZug, SwitzerlandBrisbane, United States
StatusActiveActive

Size, funding and growth

MeasureCRISPR TherapeuticsMammoth Biosciences
EmployeesNot published165
Headcount growthLast 12 monthsNot published+5.8%
Total funding$547M$460M
Latest roundSeries BFunding Round
ValuationNot published$1.1B
LinkedIn followersNot published57,986

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureCRISPR TherapeuticsMammoth Biosciences
StartupHub scoreOur 0-100 rating64/10063/100
Traction40/10060/100
Team70/10070/100
Search visibility13/10035/100
Quality88/10068/100
Agent readinessHow well an AI agent can read and act on the siteD (44/100)F (35/100)
Domain ratingLink authority, 0-10067/10053/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureCRISPR TherapeuticsMammoth Biosciences
HostingSelf ManagedNot detected
CMSNot detectedWordPress
FrameworksJqueryJquery
AnalyticsGoogle Analytics 4Google Analytics 4

CRISPR Therapeutics vs Mammoth Biosciences: common questions

Which is better, CRISPR Therapeutics or Mammoth Biosciences?

On our 0-100 score CRISPR Therapeutics rates higher (64/100 against 63/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.

How do CRISPR Therapeutics and Mammoth Biosciences compare on the numbers?

CRISPR Therapeutics leads on agent readiness (44/100 against 35/100), domain rating (67/100 against 53/100).

Read the full CRISPR Therapeutics review and pricing or the Mammoth Biosciences review and pricing. You can also browse other CRISPR Therapeutics alternatives we track.